Results for tag: "Medullary Thyroid Cancer Drugs"

Medullary Thyroid Cancer (MTC) Drugs are a subset of Thyroid Cancer Drugs used to treat MTC, a rare form of thyroid cancer. MTC Drugs are typically used in combination with surgery and radiation therapy to treat the disease. These drugs are designed to target the cancer cells and stop them from growing and spreading. Common MTC Drugs include vandetanib, cabozantinib, and lenvatinib. These drugs work by blocking the action of certain proteins that are involved in the growth and spread of cancer cells. MTC Drugs are typically administered orally or intravenously. Side effects of these drugs may include nausea, vomiting, diarrhea, fatigue, and hair loss. In some cases, MTC Drugs may also cause serious side effects such as liver damage, heart problems, and blood clots. Companies in the Medullary Thyroid Cancer Drugs market include AstraZeneca, Pfizer, Merck, and Novartis. Show Less Read more